MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ZBIO has $747,682K in assets. $411,853K in debts. $500,224K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1193.84%
Quick Ratio
1193.84%
Cash Ratio
817.88%
Debt to Asset Ratio
55.08%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible senior notes, net
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
500,224 110,641 115,565 44,006
Short-term investments
216,981 232,551 175,319 229,273
Prepaid expenses and other current assets
12,959 7,979 5,758 5,324
Total current assets
730,164 351,171 296,642 278,603
Property and equipment, net
28 34 50 61
Operating lease right-of-use assets, net
1,090 1,354 807 1,010
Long-term investments
1,340 17,272 10,717 1,614
Other non-current assets
15,060 13,809 13,802 11,797
Total assets
747,682 383,640 322,018 293,085
Accounts payable
8,944 7,111 6,444 7,931
Accrued expenses
51,180 54,423 45,359 44,520
Operating lease liabilities, current
1,037 1,115 618 793
Total current liabilities
61,161 62,649 52,421 53,244
Royalty obligation
84,900 ---
Senior secured term loan, net
72,084 ---
Royalty obligation
-78,636 72,989 -
Convertible senior notes, net
193,631 ---
Operating lease liabilities, less current portion
77 211 180 215
Total long-term liabilities
350,692 78,847 73,169 -
Total liabilities
411,853 141,496 125,590 53,459
Common stock, par value 0.0001 per share 175,000,000 shares authorized at march 31, 2026 and december 31, 2025, respectively 62,383,377 and 54,485,518 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
6 5 4 4
Additional paid-in capital
1,182,315 1,007,331 721,179 712,903
Accumulated other comprehensive loss
-377 -64 -69 -94
Accumulated deficit
-846,115 -765,128 -524,686 -473,187
Total stockholders' equity
335,829 242,144 196,428 239,626
Total liabilities and stockholders' equity
747,682 383,640 322,018 293,085
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$500,224K Short-term investments$216,981K Prepaid expenses andother current assets$12,959K Total current assets$730,164K Other non-currentassets$15,060K Long-term investments$1,340K Operating leaseright-of-use assets, net$1,090K Property and equipment,net$28K Total assets$747,682K Total liabilities andstockholders' equity$747,682K Total liabilities$411,853K Total stockholders'equity$335,829K Accumulated deficit-$846,115K Accumulated othercomprehensive loss-$377K Total long-termliabilities$350,692K Total currentliabilities$61,161K Additional paid-in capital$1,182,315K Common stock, par value0.0001 per share...$6K Convertible senior notes,net$193,631K Royalty obligation$84,900K Senior secured termloan, net$72,084K Operating leaseliabilities, less current...$77K Accrued expenses$51,180K Accounts payable$8,944K Operating leaseliabilities, current$1,037K

Zenas BioPharma, Inc. (ZBIO)

Zenas BioPharma, Inc. (ZBIO)